Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2023		14,600,766
Beginning balance at Dec. 31, 2023	$ 636,094	$ 146	$ 206,197	$ 421,980	$ 7,771
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income	6,849			6,849
Other comprehensive income, net of tax	2,243				2,243
Employee stock purchase plan (in shares)		28,773
Employee stock purchase plan	1,190		1,190
Stock options exercised (in shares)		1,625
Stock options exercised	47		47
Stock awards vested (in shares)		152,569
Stock awards vested	0	$ 2	(2)
Stock repurchased related to the exercise of stock options and stock awards vested (in shares)		(77,107)
Stock repurchased related to the exercise of stock options and stock awards vested	(3,765)	$ (1)	(3,764)
Stock-based compensation	2,889		2,889
Ending balance (in shares) at Mar. 30, 2024		14,706,626
Ending balance at Mar. 30, 2024	$ 645,547	$ 147	206,557	428,829	10,014
Beginning balance (in shares) at Dec. 31, 2024	14,781,218	14,781,218
Beginning balance at Dec. 31, 2024	$ 682,530	$ 148	217,523	453,475	11,384
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net Income	10,511			10,511
Other comprehensive income, net of tax	(2,354)				(2,354)
Employee stock purchase plan (in shares)		24,412
Employee stock purchase plan	1,294	$ 1	1,293
Stock awards vested (in shares)		123,580
Stock awards vested	0	$ 1	(1)
Stock repurchased related to the exercise of stock options and stock awards vested (in shares)		(60,905)
Stock repurchased related to the exercise of stock options and stock awards vested	(3,560)	$ (1)	(3,559)
Stock-based compensation	$ 4,586		4,586
Ending balance (in shares) at Mar. 29, 2025	14,868,305	14,868,305
Ending balance at Mar. 29, 2025	$ 693,007	$ 149	$ 219,842	$ 463,986	$ 9,030